FDA Approves Supplement for Bicillin L-A by King Pharmaceuticals
The FDA has granted approval for a supplemental application for Bicillin L-A, containing Penicillin G Benzathine.
Company
Pharmaceutical intelligence for King Pharmaceuticals with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.